Chemical Compound

Clofazimine; N,5-Bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine; 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-; Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-; 2-(4-Chloroanilino)-3-isopropylimino-5-(4-chlorophenyl)-3,5-dihydrophenazine; 2-p-Chloroanilino-5-p-chlorophenyl-3,5-dihydro-3-isopropyliminophenazine; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; B 663; B 663 (pharmaceutical); Chlofazimine; Clofazimine; G 30320; Hansepran; Lampren; Lamprene; NSC 141046

CAS Registry Number 2030-63-9
返回搜索 申请报价
Clofazimine; N,5-Bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine; 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-; Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-; 2-(4-Chloroanilino)-3-isopropylimino-5-(4-chlorophenyl)-3,5-dihydrophenazine; 2-p-Chloroanilino-5-p-chlorophenyl-3,5-dihydro-3-isopropyliminophenazine; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; B 663; B 663 (pharmaceutical); Chlofazimine; Clofazimine; G 30320; Hansepran; Lampren; Lamprene; NSC 141046 结构式
Primary record

Clofazimine; N,5-Bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine; 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-; Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-; 2-(4-Chloroanilino)-3-isopropylimino-5-(4-chlorophenyl)-3,5-dihydrophenazine; 2-p-Chloroanilino-5-p-chlorophenyl-3,5-dihydro-3-isopropyliminophenazine; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; B 663; B 663 (pharmaceutical); Chlofazimine; Clofazimine; G 30320; Hansepran; Lampren; Lamprene; NSC 141046

库存
7,632 克
纯度
99.8 %
CAS
2030-63-9

化合物标识与属性

CAS
2030-63-9
PubChem CID
2794
SMILES
CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl
Canonical SMILES
CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1

名称与同义词

  • clofazimine
  • Lamprene
  • Chlofazimine
  • Lampren
  • Clofazimina
  • Clofaziminum
  • 2030-63-9
  • Riminophenazine
  • Colfazimine
  • Clofazimine RS
  • Clofaziminum [INN-Latin]
  • B 663 (Pharmaceutical)
  • Clofazimine CRS
  • Clofazimina [INN-Spanish]
  • Lamprene (TN)
  • Prestwick_685
  • NSC-141046
  • C27H22Cl2N4
  • B 663, pharmaceutical
  • VINYLMETHACRYLATE
  • Clofazimine (Standard)
  • CLOFAZIMINE 1G
  • CLOFAZIMINE 5G
  • D959AE5USF
  • (non-d)Clofazimine-d7
  • RefChem:57185
  • UNII-D959AE5USF
  • DTXSID7022839
  • AC1L1EHE
  • B-663[Pharmaceutical]
  • CLOFAZIMINE [MI]
  • Clofazimine [USAN:INN:BAN]
  • Prestwick0_000376
  • Prestwick1_000376
  • Prestwick2_000376
  • Prestwick3_000376
  • CLOFAZIMINE [INN]
  • CLOFAZIMINE [JAN]
  • CLOFAZIMINE [USAN]
  • Clofazimine (JAN/USP/INN)
  • D07NPR
  • D0S5UH
  • B-663
  • CLOFAZIMINE [VANDF]
  • COLFAZIMINE [VANDF]
  • B 663 (VAN)
  • cid_2794
  • G 30320
  • CHEBI:3749
  • CHEMBL1292
  • CLOFAZIMINE [MART.]
  • BIDD:PXR0147
  • SCHEMBL26757
  • SCHEMBL26758
  • BSPBio_000531
  • CHEMBL1083384
  • CLOFAZIMINE [USP-RS]
  • CLOFAZIMINE [WHO-DD]
  • CLOFAZIMINE [WHO-IP]
  • Liposome-encapsulated clofazimine
  • MLS000028617
  • MLS001424318
  • MLS006010789
  • EINECS 217-980-2
  • N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine
  • SPBio_002452
  • Clofazimine [USAN:BAN:INN]
  • MFCD00056793
  • NSC141046
  • WDQPAMHFFCXSNU-UHFFFAOYSA-N
  • BPBio1_000585
  • DTXCID302839
  • GTPL9184
  • orb1310671
  • SCHEMBL5663361
  • B 663
  • Clofazimine [USAN:USP:INN:BAN]
  • NSC 141046
  • SCHEMBL29370522
  • SCHEMBL29373918
  • CTK6H0611
  • ERK5-2B20
  • HY-B1046R
  • BRN 0060420
  • CID2794
  • CLOFAZIMINE [ORANGE BOOK]
  • g30320
  • J04BA01
  • G-30320
  • MMV687800
  • WDQPAMHFFCXSNU-KRUMMXJUSA-N
  • B663
  • C27-H22-Cl2-N4
  • CLOFAZIMINE [EP MONOGRAPH]
  • CLOFAZIMINE [USP IMPURITY]
  • DTXCID301064997
  • GLXC-06907
  • HMS1569K13
  • HMS2052B05
  • HMS2093J10
  • HMS2096K13
  • HMS2231B04
  • HMS3370N05
  • HMS3394B05
  • HMS3652A16
  • HMS3713K13
  • HMS5082M14
  • KUC109573N
  • Pharmakon1600-01505974
  • CLOFAZIMINE [USP MONOGRAPH]
  • AMY22515
  • BCP07792
  • CID:2794
  • CLOFAZIMINUM [WHO-IP LATIN]
  • DRG-0067
  • HY-B1046
  • KS-00000XN9
  • KSC-27-052A
  • SMP2_000339
  • Tox21_110516
  • BDBM50318909
  • BDBM50378783
  • EBC-13571
  • MSK159113
  • NCGC00016600-01
  • NSC759283
  • s4107
  • ZINC17953024
  • CPD000058704
  • AKOS015896438
  • AKOS026749881
  • Clofazimine for system suitability CRS
  • ZINC100037101
  • ZINC253916263
  • AC20496
  • CAS-2030-63-9
  • CCG-101159
  • CCG-269477
  • CS-4567
  • CS-O-01721
  • CS-O-11002
  • DB00845
  • J9.543E
  • KS-1412
  • NC00409
  • NSC-759283
  • Riminophenazine (tuberculosis infection)
  • NCGC00016600-02
  • NCGC00016600-03
  • NCGC00016600-04
  • NCGC00016600-05
  • NCGC00016600-07
  • NCGC00016600-08
  • NCGC00016600-09
  • NCGC00179529-01
  • 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin
  • 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
  • AC-38030
  • AK544295
  • AN-16626
  • DA-72278
  • SAM001246878
  • SC-47057
  • SMR000058704
  • SMR004701474
  • B. 663
  • Clofazimine 100 microg/mL in Acetonitrile
  • G-30,320
  • Phenazine,10-dihydro-2-(isopropylimino)-
  • SBI-0206865.P001
  • SID:134223284
  • 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine
  • LS-103014
  • B1710
  • C2866
  • FT-0657414
  • G30,320
  • NS00011720
  • ST51014966
  • SW196840-4
  • Z3118
  • 4-25-00-03033 (Beilstein Handbook Reference)
  • A16462
  • C06915
  • D00278
  • EN300-267815
  • G 30,320
  • N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine
  • 2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-
  • 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine
  • 030C639
  • A814428
  • D002991
  • EN300-21680301
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine
  • Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-
  • Q418611
  • SR-01000000259
  • SR-05000001807
  • 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
  • Clofazimine =98.0% (by HPLC, titration analysis)
  • I06-1891
  • N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine
  • N,5-bis(4-chlorophenyl)-3-isopropylimino-phenazin-2-amine
  • SR-01000000259-6
  • SR-05000001807-1
  • SR-05000001807-2
  • 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]
  • BRD-K56614220-001-10-9
  • BRD-K56614220-001-18-2
  • BRD-K56614220-001-19-0
  • BRD-K56614220-001-21-6
  • Phenazine, 2,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-
  • CFZ
  • N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine
  • Z2037279473
  • 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
  • Clofazimine, European Pharmacopoeia (EP) Reference Standard
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(1-methylethyl)imino)-2-phenazinamine
  • (3E)-N,5-bis(4-chlorophenyl)-3-isopropylimino-phenazin-2-amine
  • (3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine
  • Clofazimine, United States Pharmacopeia (USP) Reference Standard
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine
  • 2-p-Chloranilino-5-p-chlorphenyl-3,5-dihydro-3-isopropylimino-phenazin
  • 2-p-chloroanilino-5-p-chlorophenyl-3,5-dihydro-3-isopropyliminophenazine
  • 3,5-Dihydro-N,5-bis(4-chlorophenyl)-3-(isopropylimino)phenazine-2-amine
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine
  • N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)-2-phenazinamine
  • (3E)-N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine
  • (4-Chloro-phenyl)-[5-(4-chloro-phenyl)-3-isopropylimino-3,5-dihydro-phenazin-2-yl]-amine
  • 2-Phenazinamine,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
  • 2-Phenazinamine,5-dihydro-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-
  • 2-Phenazinamine,N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
  • Clofazimine for system suitability, European Pharmacopoeia (EP) Reference Standard
  • N,5-Bis(4-chlorophenyl)-3-([1-methylethyl]imino)-3,5-dihydro-2-phenazinamine #
  • Phenazine,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-
  • Riminophenazine (tuberculosis infection), TB Alliance/IMM/BTTTRI/University of Illinois
  • (4-chlorophenyl)[5-(4-chlorophenyl)-3-(2-methyl-1-azapropylidene)(5-hydrophena zin-2-yl)]amine
  • 217-980-2
  • 2458811-14-6
  • ClO
  • Clofazimine; N,5-Bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine; 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-; Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-; 2-(4-Chloroanilino)-3-isopropylimino-5-(4-chlorophenyl)-3,5-dihydrophenazine; 2-p-Chloroanilino-5-p-chlorophenyl-3,5-dihydro-3-isopropyliminophenazine; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; B 663; B 663 (pharmaceutical); Chlofazimine; Clofazimine; G 30320; Hansepran; Lampren; Lamprene; NSC 141046
  • Riminophenazines (Mycobacterium tuberculosis infection), The Global Alliance for TB Drug Development/Institute of Materia Medica